Literature DB >> 6258968

Drug action on adenylate kinase activity in cerebrospinal fluid of arteriosclerotic patients.

G Frithz, G Ronquist, B Andersson.   

Abstract

A manifest presence of adenylate kinase activity in cerebrospinal fluid was found in patients with cerebral arteriosclerosis. This activity was significantly higher during treatment with co-dergocrine (Hydergin) compared with the two periods before and after treatment.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6258968     DOI： 10.1007/bf01960129

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  7 in total

1.  The influence of adrenergic effectors on the cationic pump of brain cell membrane.

Authors:  A Chappuis; A Enz; P Iwangoff
Journal:  Triangle       Date:  1975

2.  Cerebrospinal fluid content of adenylate kinase, lactate and glutathione in patients with meningitis.

Authors:  I Jonsson; H Briem; G Ronquist
Journal:  Scand J Infect Dis       Date:  1979

3.  Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 1. Structure-activity relationships of agonists and antagonists of biogenic amines and of tricyclic tranquilizers and antidepressants.

Authors:  M Huang; J W Daly
Journal:  J Med Chem       Date:  1972-05       Impact factor: 7.446

4.  The effects of a soluble factor and of catecholamines on the activity of adenosine triphosphatase in subcellular fractions of rat brain.

Authors:  A Schaefer; G Unyi; A K Pfeifer
Journal:  Biochem Pharmacol       Date:  1972-09-01       Impact factor: 5.858

5.  Cerebral metabolic changes during treatment of subacute cerebral infarction by alpha and beta adrenergic blockade with phenoxybenzamine and propranolol.

Authors:  J S Meyer; S Okamoto; K Shimazu; A Koto; T Ouchi; A Sari; A D Ericsson
Journal:  Stroke       Date:  1974 Mar-Apr       Impact factor: 7.914

6.  Adenylate kinase activity and glutathione concentration of cerebrospinal fluid in different neurological disorders.

Authors:  G Ronquist; G Frithz
Journal:  Eur Neurol       Date:  1979       Impact factor: 1.710

7.  Adenylate kinase activity in cerebrospinal fluid of schizophrenic and certain other psychiatric symptomatologies.

Authors:  P O Alm; G Frithz; G Ronquist
Journal:  Acta Psychiatr Scand       Date:  1979-05       Impact factor: 6.392
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.